Rapport Therapeutics, Inc.
RAPP
33 insider filings · Latest: Aug 10, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Apr 14, 2026 | Apr 14 8:13 PM | Krishnaswamy YeleswaramChief Development Officer | Sale | 10,200 | $35.08 | $357.8K | 266,651(D) | View → |
| Apr 13, 2026 | Apr 14 8:13 PM | Krishnaswamy YeleswaramChief Development Officer | Sale | 9,165 | $34.97 | $320.5K | 276,851(D) | View → |
| Apr 10, 2026 | Apr 14 8:13 PM | Krishnaswamy YeleswaramChief Development Officer | Sale | 500 | $34.98 | $17.5K | 286,016(D) | View → |
| Apr 13, 2026 | Apr 13 8:37 PM | KRISHNASWAMY YELESWARAM | Proposed Sale | 19,365 | $34.17 | $661.7K | — | View → |
| Apr 10, 2026 | Apr 10 8:34 PM | KRISHNASWAMY YELESWARAM | Proposed Sale | 500 | $34.22 | $17.1K | — | View → |
| Apr 8, 2026 | Apr 9 8:30 PM | Krishnaswamy YeleswaramChief Development Officer | Sale | 360 | $34.90 | $12.6K | 286,516(D) | View → |
| Apr 8, 2026 | Apr 8 9:35 PM | KRISHNASWAMY YELESWARAM | Proposed Sale | 360 | $33.49 | $12.1K | — | View → |
| Mar 30, 2026 | Mar 31 8:27 PM | Cheryl GaultChief Operating Officer | Sale | 10,000 | $28.19 | $281.9K | 159,914(D) | View → |
| Mar 30, 2026 | Mar 30 9:31 PM | CHERYL GAULT | Proposed Sale | 10,000 | $27.84 | $278.4K | — | View → |
| Mar 25, 2026 | Mar 26 8:41 PM | Krishnaswamy YeleswaramChief Development Officer | Sale | 10,115 | $29.99 | $303.4K | 286,876(D) | View → |
| Mar 25, 2026 | Mar 25 8:22 PM | KRISHNASWAMY YELESWARAM | Proposed Sale | 10,115 | $28.25 | $285.7K | — | View → |
| Mar 5, 2026 | Mar 9 8:07 PM | Cheryl GaultChief Operating Officer | Sale | 2,014 | $28.93 | $58.3K | 169,914(D) | View → |
| Mar 5, 2026 | Mar 5 10:54 PM | Gault Cheryl | Proposed Sale | 2,014 | $28.92 | $58.2K | — | View → |
| Feb 18, 2026 | Feb 20 12:06 AM | Abraham CeesayDirector, Chief Executive Officer | Sale | 10,916 | $29.35 | $320.4K | 20,729(I) | View → |
| Feb 17, 2026 | Feb 20 12:05 AM | David BredtChief Scientific Officer | Sale | 8,500 | $29.02 | $246.7K | 387,075(D) | View → |
| Jan 20, 2026 | Jan 23 12:00 AM | Abraham CeesayDirector, Chief Executive Officer | Sale | 10,916 | $26.11 | $285.1K | 25,812(I) | View → |
| Jan 15, 2026 | Jan 16 9:06 PM | David BredtChief Scientific Officer | Sale | 8,500 | $26.84 | $228.1K | 395,575(D) | View → |
| Jan 15, 2026 | Jan 15 9:28 PM | DAVID BREDT | Proposed Sale | 17,000 | $27.42 | $466.1K | — | View → |
| Jan 2, 2026 | Jan 3 1:20 AM | DAVID BREDT | Proposed Sale | 6,567 | $30.05 | $197.3K | — | View → |
| Jan 2, 2026 | Jan 3 1:17 AM | Krishnaswamy Yeleswaram | Proposed Sale | 2,840 | $30.05 | $85.3K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Jun 10, 2026 | Jun 10 9:57 PM | John MaraganoreDirector | Grant/Award | 15,200 | $35.21 | 15,200(D) | View → |
| Jun 10, 2026 | Jun 10 9:52 PM | Robert J PerezDirector | Grant/Award | 15,200 | $35.21 | 15,200(D) | View → |
| Jun 10, 2026 | Jun 10 9:46 PM | Steven M PaulDirector | Grant/Award | 15,200 | $35.21 | 15,200(D) | View → |
| Jun 10, 2026 | Jun 10 9:28 PM | Paul M SilvaDirector | Grant/Award | 15,200 | $35.21 | 15,200(D) | View → |
| Jun 10, 2026 | Jun 10 9:26 PM | James HealyDirector | Grant/Award | 15,200 | $35.21 | 15,200(D) | View → |
| Jun 10, 2026 | Jun 10 9:25 PM | Reid M HuberDirector | Grant/Award | 15,200 | $35.21 | 15,200(D) | View → |
| Jun 10, 2026 | Jun 10 9:24 PM | Wendy B. YoungDirector | Grant/Award | 15,200 | $35.21 | 15,200(D) | View → |
| Jun 10, 2026 | Jun 10 9:23 PM | Ramiro SanchezDirector | Grant/Award | 15,200 | $35.21 | 15,200(D) | View → |
| Feb 19, 2026 | Feb 20 12:05 AM | David BredtChief Scientific Officer | Option Exercise | 6,000 | $1.80 | 88,080(D) | View → |
| Feb 2, 2026 | Feb 4 9:15 PM | Jeffrey SevignyChief Medical Officer | Grant/Award | 130,000 | $27.75 | 130,000(D) | View → |
| Feb 2, 2026 | Feb 4 9:14 PM | Abraham CeesayDirector, Chief Executive Officer | Grant/Award | 428,000 | $27.75 | 428,000(D) | View → |
| Feb 2, 2026 | Feb 4 9:12 PM | Troy A. IgnelziChief Financial Officer | Grant/Award | 148,000 | $27.75 | 148,000(D) | View → |
| Feb 2, 2026 | Feb 4 9:11 PM | Krishnaswamy YeleswaramChief Development Officer | Grant/Award | 120,000 | $27.75 | 120,000(D) | View → |
| Feb 2, 2026 | Feb 4 9:09 PM | David BredtChief Scientific Officer | Grant/Award | 103,000 | $27.75 | 103,000(D) | View → |
| Feb 2, 2026 | Feb 4 9:02 PM | Cheryl GaultChief Operating Officer | Grant/Award | 132,000 | $27.75 | 132,000(D) | View → |